Stock Taper
SCREENER COMPARE ANY 2 STOCKS
HAE
HAEMONETICS CORPORATION
NYSE
$103.96
▼ DOWN 0.99% (-1.04)

KEY STATISTICS

Market Cap$4.72 B
52w High$109.57
52w Low$47.32
Dividend Yield—
Frequency—
P/E20.75
Volume659.18K
Shares Out.45.45M

COMPANY

LEADERSHIP

Christopher A. Simon
CHIEF EXECUTIVE
Christopher A. Simon

COMPENSATION 2026

Salary$1,100,008
Stock Awards$7,561,987
Incentive Plan Pay$1,834,250
All Other Comp.$43,488
Total$12,044,701

ABOUT

SECTOR
Healthcare
WENT PUBLIC
May 10, 1991
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
3,009

PRICE TARGET

Target High$119.00
Target Low$85.00
Target Median$105.00
Target Consensus$104.60

UPCOMING EARNINGS

DateNov 5, 2026
DayThursday
Rev. Est.$345.03M
NOV
5
THU

SPLIT RECORD

DATETYPERATIO
2012-12-03Forward2:1
1993-01-11Forward2:1

PRICE

$103.96 ▼ DOWN 0.99% (−$1.04)
OVERLAYS
$104$104$105$1069:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM103.96

About Haemonetics Corporation

https://www.haemonetics.com ↗

Haemonetics Corporation provides medical devices and solutions for plasma collection, blood processing, and hospital blood management, serving healthcare providers worldwide through its segmented plasma, blood center, and hospital products.

INDUSTRY

Medical - Devices

A PRODUCT HAEMONETICS CORPORATION IS KNOWN FOR

PerQseal Elite Vascular Closure System
PerQseal Elite Vascular Closure System

Haemonetics' fully absorbable, sutureless system closes large-bore arteriotomies and venotomies from inside the vessel, marking its strategic expansion into the high-growth interventional cardiology market via the Vivasure Medical acquisition.

COMPETITORS

COMPETITOR
ABT COMPARE
BSX COMPARE
MDT COMPARE
MMSI COMPARE
TFX COMPARE

Revenue by Products

IconPRODUCTQ2-2026Q3-2026Q4-2026Q1-2027
Hemostasis Management Hospital$86.42M $87.45M ▲$180.43M ▲—
Hospital$145.5M $143.5M ▼$159.65M ▲—
Apheresis— — — $155.52M
Plasma$125.36M $138.91M ▲$130.29M ▼—
Interventional Technologies Hospital$59.07M $56.05M ▼$118.88M ▲—
Apheresis Blood Center$56.06M $56.56M ▲$108.24M ▲—
Blood Center$56.45M $56.56M ▲$56.41M ▼—
Whole Blood Blood Center$389K — $17K ▼—

Revenue by Geography

MapREGIONQ2-2026Q3-2026Q4-2026Q1-2027
UNITED STATES$482.49M $730.21M ▲$0 ▼$257.84M ▲
Europe$83.85M $132.12M ▲$0 ▼$45.53M ▲
Asia$44.22M $67.24M ▲$0 ▼$20.16M ▲
JAPAN$31.66M $49.8M ▲$0 ▼$12.86M ▲
Other Country or Region$6.5M $8.31M ▲$0 ▼$2.99M ▲

ETFS HOLDING THIS STOCK

ETFS HOLDING
218
LISTED HERE
26
RANKED BY POSITION SIZE
XMC.TO
0.14% · 1.6M
VTI
0.01% · 1.4M
MDY
0.13% · 340.4K
SCHA
0.10% · 220.4K
VETS
0.39% · 205.9K
DFMC
0.21% · 156.9K
PSC
0.50% · 133.7K
JSMD
1.11% · 113.0K
AVSC
0.28% · 85.6K
PRFZ
0.28% · 75.7K
JMEE
0.25% · 70.0K
FESM
0.09% · 54.1K
FYC
0.37% · 50.7K
XRS2.DE
0.15% · 42.9K
TMAT
1.27% · 31.2K
NUSC
0.18% · 25.3K
NBSM
2.10% · 23.3K
RSSL
0.15% · 22.5K
WSCSRI.SW
0.18% · 14.4K
SIXL
0.66% · 13.0K
EZM
0.14% · 12.7K
ETHO
0.53% · 10.0K
ISMD
0.28% · 9.1K
TPSC
0.23% · 8.4K
GVLU
0.26% · 6.4K
ROSC
1.05% · 5.4K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
84.87%
HOLDERS
544
TOP 12 OF 544 · RANKED BY POSITION SIZE
Blackrock, Inc.
6.0M sh · $293.45M
Blackrock Inc.
6.0M sh · $493M
Vanguard Group Inc
4.8M sh · $235.64M
Neuberger Berman Group LLC
4.2M sh · $313.47M
Blackrock Fund Advisors
4.1M sh · $166.32M
Aqr Capital Management LLC
3.4M sh · $185.68M
Ariel Investments, LLC
2.1M sh · $154.57M
State Street Corp
1.8M sh · $136.36M
River Road Asset Management, LLC
1.7M sh · $80.65M
Dimensional Fund Advisors LP
1.6M sh · $118.89M
Citadel Advisors LLC
1.5M sh · $113.26M
Ubs Group AG
1.5M sh · $70.8M

RATINGS SNAPSHOT

Overall rating: B

DCFROEROAD/EP/EP/B
Discounted Cash Flow4
Return On Equity4
Return On Assets4
Debt To Equity1
Price To Earnings1
Price To Book2
Overall Score3

TRADES BY CONGRESS

HOUSE TRADES
Lois Frankel
Lois Frankel
Sale (Full)
2021-05-07
 Josh Gottheimer
Josh Gottheimer
Sale (Full)
2021-01-25
 Gilbert Cisneros
Gilbert Cisneros
Purchase
2020-06-01

INSIDER TRADES

★
DIRECTOR
Johnson Lloyd Emerson
Purchase · 2.5K shares
2026-07-24
★
DIRECTOR
ABERNATHY ROBERT E
Purchase · 2.5K shares
2026-07-24
★
DIRECTOR:
Madaus Martin D
— · —
2026-07-24
★
DIRECTOR
Zane Ellen M
Purchase · 2.5K shares
2026-07-24

MOST RECENT ANALYST GRADES

GRADE SUMMARY
OUTPERFORM 3
BUY 2
NEUTRAL 2
HOLD 1
8 GRADES IN THE LAST 12 MONTHS
Baird OUTPERFORM Barrington Research OUTPERFORM BTIG BUY JP Morgan NEUTRAL Citigroup NEUTRAL Mizuho OUTPERFORM B of A Securities BUY Needham HOLD

SECTORS PEERS

PEERPRICE
CON$34.26COMPARE
ITGR$125.33COMPARE
WRBY$25.00COMPARE
BEAM$29.32COMPARE
BHC$6.32COMPARE
XRAY$11.12COMPARE
LMAT$80.45COMPARE
QDEL$14.74COMPARE